Catherine A. Vaughan

716 citations

21 papers · 552 indexed · h-index 14

Co-authors: Sumitra Deb W. Andrew Yeudall Swati Palit Deb Brad E. Windle Shilpa Singh Mahesh Ramamoorthy Liane B. Russell B E Windle
Topics: Cancer-related Molecular Pathways (15 papers)Cancer Research and Treatments (6 papers)Epigenetics and DNA Methylation (6 papers)
Cited by: Oncology Biotechnology Cancer Research
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Journal of Clinical Investigation
Partner nations: United States Finland

In The Last Decade

Catherine A. Vaughan

21 papers receiving 532 citations

Peers

Countries citing papers authored by Catherine A. Vaughan

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Vaughan more than expected).

Fields of papers citing papers by Catherine A. Vaughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Vaughan. The network helps show where Catherine A. Vaughan may publish in the future.

Co-authorship network of co-authors of Catherine A. Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Vaughan. A scholar is included among the top collaborators of Catherine A. Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Vaughan. Catherine A. Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3 2021 ·Nature Communications ·Catherine A. Vaughan,Shilpa Singh,Mark A. Subler,Jolene J. Windle,Kazushi Inoue,Elizabeth A. Fry,(unknown),Steven R. Grossman,Brad E. Windle,W. Andrew Yeudall,Swati Palit Deb,Sumitra Deb	18
2	DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2 2019 ·JCI Insight ·Shilpa Singh,Catherine A. Vaughan,(unknown),Ross B. Mikkelsen,Sumitra Deb,Swati Palit Deb	12
3	Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells 2017 ·Molecular Oncology ·Catherine A. Vaughan,Shilpa Singh,Steven R. Grossman,Brad E. Windle,Swati Palit Deb,Sumitra Deb,(unknown),(unknown)	14
4	Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication 2017 ·Journal of Clinical Investigation ·Shilpa Singh,Catherine A. Vaughan,(unknown),Steven R. Grossman,Sumitra Deb,Swati Palit Deb	34
5	Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter 2016 ·Oncotarget ·Catherine A. Vaughan,Isabella Pearsall,Shilpa Singh,Brad E. Windle,Swati Palit Deb,Steven R. Grossman,W. Andrew Yeudall,Sumitra Deb	17
6	p53: Its Mutations and Their Impact on Transcription 2014 ·Sub-cellular biochemistry ·Catherine A. Vaughan,Isabella Pearsall,W. Andrew Yeudall,Swati Palit Deb,Sumitra Deb	29
7	Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites 2014 ·Oncotarget ·Catherine A. Vaughan,Swati Palit Deb,Sumitra Deb,Brad E. Windle	12
8	The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing 2013 ·Nucleic Acids Research ·(unknown),Sandeep K. Singh,Catherine A. Vaughan,Nitai D. Mukhopadhyay,(unknown),B E Windle,Sumitra Deb	28
9	Allele specific gain-of-function activity of p53 mutants in lung cancer cells 2012 ·Biochemical and Biophysical Research Communications ·Catherine A. Vaughan,(unknown),Isabella Pearsall,Shilpa Singh,Brad E. Windle,W. Andrew Yeudall,Swati Palit Deb,Sumitra Deb,(unknown),(unknown)	20
10	Measurement of Chemosensitivity and Growth Rate in p53 Expressing Cells 2012 ·Methods in molecular biology ·Mahesh Ramamoorthy,Catherine A. Vaughan,Sumitra Deb,Swati Palit Deb	1
11	Gain-of-Function Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl 2012 ·Genes & Cancer ·Catherine A. Vaughan,Sandeep K. Singh,B E Windle,W. Andrew Yeudall,(unknown),(unknown),Sumitra Deb	55
12	ChIP Sequencing to Identify p53 Targets 2012 ·Methods in molecular biology ·Catherine A. Vaughan,Brad Windle,Sumitra Deb	3
13	Isolation and Characterization of Murine Multipotent Lung Stem Cells 2012 ·Methods in molecular biology ·(unknown),Catherine A. Vaughan,Raj R. Rao	15
14	Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells 2012 ·Cell Death and Differentiation ·(unknown),Mahesh Ramamoorthy,Catherine A. Vaughan,W. Andrew Yeudall,Sumitra Deb	32
15	Generation of p53 Knock-down Cell Lines 2012 ·Methods in molecular biology ·Catherine A. Vaughan,Swati Palit Deb,Sumitra Deb	1
16	Human Oncoprotein MDM2 Up-regulates Expression of NF- B2 Precursor p100 Conferring a Survival Advantage to Lung Cells 2011 ·Genes & Cancer ·Catherine A. Vaughan,Lathika Mohanraj,Sandeep K. Singh,Catherine I. Dumur,Mahesh Ramamoorthy,Carleton T. Garrett,B E Windle,W. Andrew Yeudall,Sumitra Deb,Swati Palit Deb	13
17	Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration 2011 ·Carcinogenesis ·W. Andrew Yeudall,Catherine A. Vaughan,Hiroshi Miyazaki,Mahesh Ramamoorthy,(unknown),Christopher G. Chapman,Hui‐Xin Wang,(unknown),Anna Bulysheva,Swati Palit Deb,Brad E. Windle,Sumitra Deb	103
18	Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance 2011 ·Archives of Biochemistry and Biophysics ·Heidi Sankala,Catherine A. Vaughan,Jing Wang,Sumitra Deb,Paul R. Graves	30
19	p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity 2011 ·Archives of Biochemistry and Biophysics ·Catherine A. Vaughan,Shilpa Singh,Brad E. Windle,Heidi Sankala,Paul R. Graves,W. Andrew Yeudall,Swati Palit Deb,Sumitra Deb	49
20	Upregulation of the Mitochondrial Transport Protein, Tim50, by Mutant P53 Contributes to Cell Growth and Chemoresistance 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Paul R. Graves,Heidi Sankala,(unknown),Catherine A. Vaughan,Sumitra Deb	1

About Catherine A. Vaughan

Catherine A. Vaughan is a scholar working on Biotechnology, Oncology and Cancer Research, having authored 21 papers that have together received 552 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), Cancer Research and Treatments (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Oncology (330 citations), Biotechnology (74 citations) and Cancer Research (121 citations). Catherine A. Vaughan has collaborated with scholars based in United States and Finland. Frequent co-authors include Sumitra Deb, W. Andrew Yeudall, Swati Palit Deb, Brad E. Windle, Shilpa Singh, Mahesh Ramamoorthy, Liane B. Russell, B E Windle, R A Popp and Sandeep K. Singh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact